InCrowd Caps Impressive Growth in 2018 by Answering its 2.5 Millionth Question

InCrowd, pioneer of the real-time market intelligence platform for the life sciences, concluded another year of impressive business growth in 2018 by answering its 2.5 millionth question posed by biotech, life sciences, and medical device firms to its Crowd of healthcare professionals. The milestone reflects increasing awareness that managing brand health through fast, reliable, quality insights is a strategic imperative for gaining a competitive advantage.

Weve experienced stronger, scalable growth, spread across more and more clients every quarter, allowing us to deliver greater value to our customers and the market faster, said Janet Kosloff, InCrowd CEO and co-founder. After moving to our new corporate headquarters in early 2018 to accommodate our growth we organized around a new product approach with a goal of honing our commercialization efforts to bring value to customers faster. And weve kicked off 2019 stronger than any year to date.

Notable accomplishments achieved in part from InCrowds customer-focused strategy include:

InnovationInCrowd continued to evolve its market-leading, insights on-demand platform, bringing greater respondent personalization and advanced analytics to market in 2018 with features such as carry-forward answers, skip logic, and cross tabulation reporting, among other platform advancements. InCrowd also continues to expand on-demand qualitative research with its new DIY qualitative solution, InCrowd Interviewcurrently in use with early adopters.


Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

GrowthInCrowd added more than 100 new brands in 2018 and is now a key partner in managing the health of 300 life science brands. With more than 20 new life science firms on its roster of marquee clients, InCrowd now serves 40 of the top 100 global pharma companies. Fortifying its existing team of talented insights experts, InCrowd brought on executive-level hires including a new head of product, several director-level positions in product, client success, and analytics, as well as seasoned business development leaders.

RecognitionThe pharmaceutical marketing magazine PM360 named InCrowd Interview one of the most innovative products of 2018 in December. InCrowd Interview also received a Bronze Stevie Award in November for Best New Product of the Year from the American Business Awards Women in Business program. PM360 named InCrowd a finalist in its annual Trailblazer Awards in August, a program commending industry commitment to change and corporate social responsibility. The Boston Business Journal recognized InCrowd as one of Massachusetts top mobile technology companies in April.

For more information regarding InCrowd’s research, please contact InCrowd.

About InCrowd InCrowd is the pioneer of the real-time, mobile, MicroSurvey solution delivering top US life science firms agile, primary market research. InCrowd has access to a 1.8 million Crowd of healthcare professionals worldwide, reached in 20 languages. Serving more than 300 brands, InCrowd accelerates market research and time-to-respond to insights to ensure effective brand management and strong brand health.

InCrowd Media Contacts

Meghan Oates-Zalesky
Senior Vice President of Marketing
[email protected]

Mary Kae Marinac
PR Representative for InCrowd
[email protected]